Vitamin B12 Research Today is a free monthly online journal that collates and summarizes the latest research about Vitamin B12, including details on cyanocobalamin, benefits, supplements, deficiency, side-effects, sources.

Synthesis and characterization of a cobalamin-colchicine conjugate as a novel tumor-targeted cytotoxin.

Bagnato JD, Eilers AL, Horton RA, Grissom CB

Department of Chemistry, University of Utah, Salt Lake City, Utah 84112-0850, USA.

Colchicine was derivatized at C7 with p-alkoxyacetophenone and conjugated to cobalamin (vitamin B(12)) through an acid-labile hydrazone linker. The cobalamin moiety leads to preferential uptake of the cobalamin-colchicine prodrug by cancer cells, whereupon the hydrazone linker undergoes hydrolysis in the lysosome to unmask colchicine, which acts as a potent cytotoxin by stabilizing microtubules and causing cell death. The bioconjugate is stable in cell culture media and at neutral pH but undergoes hydrolysis with a half-life of 138 min at pH 4.5. The colchicine-cobalamin bioconjugate exhibits nanomolar LC(50) values against breast, brain, and melanoma cancer cell lines in culture. Attachment of colchicine to cobalamin is expected to increase the therapeutic index of the drug by limiting the side effects caused by the current nonselective administration of tubulin-targeted chemotherapeutic drugs.

Published 21 December 2004 in J Org Chem, 69(26): 8987-96.
Full-text of this article is available online (may require subscription).

© 2004-2008 Vitamin B12 Research Today. All Rights Reserved.